We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. The imidazoline I2 receptor agonist 2-BFI reduces abuse-related effects of morphine: self-administration and drug discrimination

    Rationale

    Increasing evidence shows that imidazoline I 2 receptor agonists enhance opioid-induced analgesia, suggesting that the combination of I 2 ...

    Justin N. Siemian, Kristen Woodhouse, ... Jun-Xu Li in Psychopharmacology
    Article 30 December 2023
  2. Drug Addiction and Drug Dependency

    Drug abuse and dependency liability assessments are important components of the discovery, development, and evaluation of novel drug entities and are...
    Living reference work entry 2022
  3. Assessment of Temperature-Dependent Drug Release of Solubilizing Nanoformulations Using the SITUA

    The evaluation of temperature-dependent drug release for solubilizing nanoformulations uses a modification of the stable isotope ultrafiltration...
    Stephan T. Stern, Sarah L. Skoczen, Young Hwan Park in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  4. Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products

    Purpose

    In vitro release testing (IVRT) is a widely used tool for evaluating the quality and performance of drug products. However, standardized...

    Catheleeya Mekjaruskul, André O’Reilly Beringhs, ... **uling Lu in Pharmaceutical Research
    Article 07 September 2023
  5. Understanding the stimulus effects of nicotine and bupropion in a drug-drug discriminated goal-tracking task

    Rationale

    Bupropion is a non-nicotine medication for smoking cessation that has overlap** stimulus effects with nicotine as demonstrated in drug...

    Andrea E. Moran, Y. Wendy Huynh, ... Rick A. Bevins in Psychopharmacology
    Article 09 February 2022
  6. The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure

    Background

    Chronic oral anticancer therapies, are increasingly prescribed and present new challenges including the enhanced risk of overlooked...

    Sara Gagno, Angela Buonadonna, ... Giuseppe Toffoli in DARU Journal of Pharmaceutical Sciences
    Article Open access 15 June 2023
  7. Multiplexed discrimination of SARS-CoV-2 variants via plasmonic-enhanced fluorescence in a portable and automated device

    Portable assays for the rapid identification of lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to aid...

    Ying Liu, Yang Yang, ... Bo Zhang in Nature Biomedical Engineering
    Article 21 September 2023
  8. Role of Genomics and Proteomics in Drug Discovery

    Genomics and proteomics are two powerful technologies that are revolutionizing the drug discovery process. Genomics is the study of the entire genome...
    Jeevandran Sundarasekar, Geethaa Sahgal in Concepts in Pharmaceutical Biotechnology and Drug Development
    Chapter 2024
  9. Impact of Genetic Variation on Drug Response

    Pharmacogenomics investigates the influence of genetics on drug response, with the ultimate aim of giving patients the right drug at the right dose...
    Chapter 2023
  10. A neuromarker for drug and food craving distinguishes drug users from non-users

    Craving is a core feature of substance use disorders. It is a strong predictor of substance use and relapse and is linked to overeating, gambling,...

    Leonie Koban, Tor D. Wager, Hedy Kober in Nature Neuroscience
    Article 19 December 2022
  11. Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions

    The success of obtaining solid dispersions for solubility improvement invariably depends on the miscibility of the drug and polymeric carriers. This...

    Guilherme G. Moreira, Stephânia F. Taveira, ... Ricardo N. Marreto in AAPS PharmSciTech
    Article 06 June 2024
  12. Computer Aided Drug Design

    Various challenges such as cost and time consumption problems associated with traditional drug design and development process have been overcome with...
    Bhupinder Kumar, Pooja A. Chawla, Viney Chawla in Computer Aided Pharmaceutics and Drug Delivery
    Chapter 2022
  13. Addressing Breast Cancer Disparities in Advancements for Conquering Drug Resistance

    Breast cancer is a global concern with high morbidity and mortality rates. While incidence rates remain high in developed countries compared to...
    Rahaba Marima, Olalekan Fadebi, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  14. Relapse after intermittent access to cocaine: Discriminative cues more effectively trigger drug seeking than do conditioned cues

    Rationale

    When people with drug addiction encounter cues associated with drug use, this can trigger cravings and relapse. These cues can include...

    Ndeye Aissatou Ndiaye, Sema Abu Shamleh, ... Anne-Noël Samaha in Psychopharmacology
    Article 20 May 2024
  15. Toward a New Drug Policy Agreement

    This chapter is divided into five sections. The first one describes the beginnings and evolution of the international drug control system. The second...
    Alfredo Camhaji, Mariana Racotta, ... José Franco in Opioids
    Chapter 2022
  16. Extended Drug Access and Escalation of Drug Self-Administration

    In this chapter we first describe the intravenous drug self-administration technique in rats, with a focus on cocaine. Where relevant, we also...
    Florence Allain, Ndeye Aissatou Ndiaye, Anne-Noël Samaha in Methods for Preclinical Research in Addiction
    Protocol 2022
  17. Polypharmacology: New Paradigms in Drug Development

    Polypharmacology is the term coined for the interaction of drug molecules with multiple targets and is responsible for the side effects and...
    Tammanna R. Sahrawat, R. C. Sobti in Biomedical Translational Research
    Chapter 2022
  18. Modelling Based Approaches to Support Generic Drug Regulatory Submissions-Practical Considerations and Case Studies

    Model informed drug development (MiDD) is useful to predict in vivo exposure of drugs during various stages of the drug development process. This...

    Prajwala Karnati, Aditya Murthy, ... Tausif Ahmed in The AAPS Journal
    Article 23 June 2023
  19. Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark Study

    Drug-excipient compatibility study (DECS) is one of the critical steps during pre-formulation studies to select the appropriate excipient to obtain a...

    Sonali Jain, Ravi P. Shah in AAPS PharmSciTech
    Article 10 May 2023
  20. Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug Products

    Evidence shows that there is an increasing use of modeling and simulation to support product development and approval for complex generic drug...

    Ross L. Walenga, Andrew H. Babiskin, ... Partha Roy in The AAPS Journal
    Article 04 January 2024
Did you find what you were looking for? Share feedback.